Published in DNA Cell Biol on November 01, 2005
Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell (2011) 2.13
Mu opioids and their receptors: evolution of a concept. Pharmacol Rev (2013) 1.66
Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet (2008) 1.59
Evolution of alternative and constitutive regions of mammalian 5'UTRs. BMC Genomics (2009) 1.31
Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils. PLoS One (2010) 1.21
Opiate drug use and the pathophysiology of neuroAIDS. Curr HIV Res (2012) 1.07
Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend (2010) 1.07
Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene. J Neurochem (2008) 1.07
Cortical opioid markers in schizophrenia and across postnatal development. Cereb Cortex (2011) 1.06
The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. Neuropsychopharmacology (2011) 1.06
Opioids and their receptors: Are we there yet? Neuropharmacology (2013) 1.01
Transcriptional and epigenetic regulation of opioid receptor genes: present and future. Annu Rev Pharmacol Toxicol (2011) 0.97
Recent advances in the use of opioids for cancer pain. J Pain Res (2009) 0.95
Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity. Psychopharmacology (Berl) (2009) 0.95
Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1. Mol Pain (2011) 0.95
Molecular physiology of enteric opioid receptors. Am J Gastroenterol Suppl (2014) 0.91
Endogenous morphine in SH-SY5Y cells and the mouse cerebellum. PLoS One (2008) 0.88
A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia. AIDS (2013) 0.88
Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder. Am J Psychiatry (2010) 0.88
Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon. Gene (2007) 0.87
Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals. AIDS (2014) 0.87
Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study. Aliment Pharmacol Ther (2014) 0.87
Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P. Synapse (2014) 0.85
Opioid receptors: toward separation of analgesic from undesirable effects. Trends Biochem Sci (2013) 0.84
A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions. J Neurosci (2014) 0.84
Ultraconserved cDNA segments in the human transcriptome exhibit resistance to folding and implicate function in translation and alternative splicing. Nucleic Acids Res (2010) 0.83
Analysis of candidate genes for morphine preference quantitative trait locus Mop2. Neuroscience (2014) 0.83
Post-transcriptional regulation of mu-opioid receptor: role of the RNA-binding proteins heterogeneous nuclear ribonucleoprotein H1 and F. Cell Mol Life Sci (2011) 0.82
Differential expressions of the alternatively spliced variant mRNAs of the µ opioid receptor gene, OPRM1, in brain regions of four inbred mouse strains. PLoS One (2014) 0.82
Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family. BMC Pharmacol Toxicol (2013) 0.82
Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic mice. BMC Mol Biol (2006) 0.82
Absence of μ opioid receptor mRNA expression in astrocytes and microglia of rat spinal cord. Neuroreport (2012) 0.82
Morphine regulates expression of μ-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the μ-opioid receptor (OPRM1) gene via miR-103/miR-107. Mol Pharmacol (2013) 0.81
Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management. Mayo Clin Proc (2015) 0.81
Elucidation of mu-Opioid Gene Structure: How Genetics Can Help Predict Responses to Opioids. Eur J Pain Suppl (2011) 0.80
Gender, variation in opioid receptor genes and sensitivity to experimental pain. Mol Pain (2013) 0.79
Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV Pathogenesis. J Cell Physiol (2015) 0.78
Opioid-induced constipation: advances and clinical guidance. Ther Adv Chronic Dis (2016) 0.78
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion. ACS Chem Neurosci (2016) 0.78
Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine. J Clin Invest (2017) 0.77
Mu-opioid receptor splice variants: sex-dependent regulation by chronic morphine. J Neurochem (2014) 0.77
Splicing factor transformer-2β (Tra2β) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine. PLoS One (2013) 0.76
Changes in mouse mu opioid receptor Exon 7/8-like immunoreactivity following food restriction and food deprivation in rats. Synapse (2009) 0.76
A "tail" of opioid receptor variants. J Clin Invest (2017) 0.75
β-Adrenergic receptor gene expression in HIV-associated neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. J Neurovirol (2016) 0.75
Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits. Clin Gastroenterol Hepatol (2017) 0.75